2011 Conference Programme
Conference Hours:
23-24 February 2011
9.30 - 16.30 |
|
|
Day 1 – Wednesday 23 February 2011
|
9.30 - 15.00 |
|
|
Session 1: Regulatory Update for Combination Products in Europe and in USA: Status, Lessons and Future Vision |
|
Moderator:
|
9:30-12:00 |
Keynotes from Competent Organisations: |
|
S1-1 |
Opening Address
|
| |
 |
Dr. Yves Th. Tillet, CEO, WHITE-TILLET Consultants & Experts, France |
|
S1-2 |
Regulatory update in France
|
| |
 |
Stephane Palies, Referent for innovation, AFSSAPS |
|
|
|
|
|
10:30 -10:45 |
Coffee break, visit the exhibition |
|
|
S1-3 |
Regulatory update in UK |
| |
 |
Elizabeth Baker, Group Manager Licensing, MHRA |
|
S1-4 |
Regulatory update in USA
|
| |
 |
Jill Hartzler Warner, J. D., Acting Associate Commissioner for Special Medical Programs, US FDA |
|
| 11:30 |
Panel Discussion |
|
|
|
|
|
12:00 |
Networking lunch in the exhibition area |
|
|
| |
15:00-15:15 |
Coffee break, visit the exhibition |
|
|
| |
Day 2 – Thursday 24 February 2011
Session 3: Combination Products Today and in Future:
Drugs and Biologicals - New Delivery Systems |
|
Moderator:
|
S3-1 |
Commercializing drug device combination products - future perspectives
|
| |
 |
Crispin Simon, CEO, Biocompatibles UK Ltd |
|
S3-2 |
Overview of Injectable Drug Devices for Self-Administration Including Pens, Auto-Injectors and New Patch-Injector/Pump Devices
|
|
| |
 |
Ian Thompson, Head of Business Development, Delivery Systems,
Ypsomed AG |
|
S3-3 |
Recent Advances in Transdermal Delivery of Biologics
|
| |
 |
Steven P. Damon, Senior Vice President, Business Development, Altea Therapeutics |
|
|
|
10:55 – 11:10 |
Coffee break, visit the exhibition |
|
|
S3-4 |
Targeted Drug Delivery to the Central Nervous System (Brain and Spinal Cord)
|
| |
 |
Prof. K.K. Jain M. D, CEO, Jain PharmaBiotech |
|
S3-5 |
Combination of Diagnostics and Therapeutics
|
| |
|
Prof. K.K. Jain M. D, CEO, Jain PharmaBiotech |
|
|
|
12:00 – 13:30 |
Networking lunch in the exhibition area |
|
13:30 –16:10 |
|
Session 4: Enabling Technologies for Combination
Product Design and Development |
|
Moderator:
|
| S4-1 |
Significance of multi-responsive microgels for biomedical applications |
| |
 |
Muhammad Zafar, Research Scholar, University of Bolton |
|
| S4-2 |
Biomedical textiles in implantable medical devices |
| |
 |
Jeffrey M. Koslosky, Director of Technology & Product Development, Secant Medical LLC, USA |
|
| S4-3 |
Bioceramics as Drug Carriers for Controlled-Release Technology |
| |
 |
Dr. Xiang Zhang, Principal Consultant, Medical Materials/Devices, CERAM |
|
| S4-4 |
Peritoneal implants with controlled release of therapeutic molecules |
| |
 |
Dr. Nicolas Blanchemain, Assistant professor, Biomaterial Research Unity, Inserm Lille |
|
| S4-5 |
Cost-effective nano-coating protection of medical devices (protein resistance, anti-microbial) |
| |
 |
Dr. Delwyn Evans, Principal Chemist, P2i |
|
| S4-6 |
Combination product sterilization or packaging review |
| |
Speaker coming |
|
This panel will include 6 keynotes presenting the advances in biomaterials, surface coating technologies for drug release, combination product packaging and sterilization solutions.
Submission for conference proposals is still open till 5th December 2010. For conference submission, please contact qiaoli.vrinat@ubm.com
Presentations will be revealed at the beginning of December 2010. |
|
|
|
